LRCX Reports Tonight After a 12.5% Weekly Drop Kept Pace With Battered Peers

Lam Research closed Tuesday at $263.45, a 12.5% weekly decline that landed almost exactly at the peer median, with the results call scheduled for tonight after the bell.

The week's 12.5% drop mirrors the damage across the semiconductor equipment group almost precisely. AMAT fell 12.8% on the week. KLAC dropped 12.1%. MKSI lost 14.7%. ONTO shed 16.7%. LRCX was neither the worst nor the best performer in the cohort, which reinforces the pattern documented in the two preceding ORTEX notes: this is a sector rotation, not a company-specific story. The cumulative damage from the $348 October high now runs to roughly 24%, and the stock closed Tuesday below every current analyst price target tracked.

That last point is the most concrete tension heading into tonight. Evercore ISI's Mark Lipacis cut his target to $315 on October 20, a fresh trim tied directly to pre-earnings caution, and even that reduced figure sits 20% above the current price. Morgan Stanley raised to $385 two weeks ago. B. Riley lifted to $390 in early October. The Street has been broadly raising into the weakness, not fleeing it, with the bull case anchored to Lam's raised CY26 wafer fab equipment outlook and its etch and deposition dominance in advanced memory. Bears point to the stock's historically high beta, a China exposure that regulatory changes could disrupt at any quarter, and operating expenses that ran above guidance last cycle. The formal consensus remains a hold, but the active moves from named analysts over the past three weeks have almost all been either raises or maintained buys, a divergence from the headline rating that matters.

The lending market continues to say nothing useful about directional conviction. Short interest is at 2% of the free float, essentially flat on the week and less than half the roughly 4% readings seen in mid-September. Borrow availability is effectively uncapped. Cost to borrow ticked up 65% on a weekly basis to 0.40%, but from such a low base that the absolute level is still negligible. There is no squeeze dynamic, no crowded short, and no accumulation of borrowed shares into tonight's print. Options positioning has actually moved in a more constructive direction: the put/call ratio dipped to 1.09, more than two standard deviations below its 20-day average of 1.14. That is the lowest defensive reading in over a year, suggesting options traders reduced their put hedges into the event rather than adding them, an unusual stance after a 24% drawdown.

The earnings history gives the sharpest context for what tonight could mean. The two most recent quarterly prints each produced double-digit next-day gains: plus 10.4% after the July 29 release and plus 16.1% after the July 30 figures. The five-day returns were even larger, at 14% and 21% respectively. Both came from stock levels well below prevailing analyst targets, a situation that now repeats. That pattern does not predict tonight's outcome, but it does frame what the market has been willing to pay for a clean LRCX result when sentiment has already been depressed. Wikipedia page views for Lam are running at a z-score of 4.2 against the prior 90 days, an unusually sharp spike in retail attention that the ORTEX alt data layer flagged as of October 13.

The number to watch is guidance. The pre-print debate is less about whether Lam beats this quarter and more about whether management reaffirms or raises its CY26 WFE outlook above $140 billion, and what they say about CY27 setup. Analyst targets clustering in the $315 to $425 range with the stock at $263 means the valuation gap is already wide enough that the P/E, currently 23x on trailing figures, would re-rate sharply on any upward revision to that framework.